Skip to main content
Log in

Synthesis and Anti-Monoamine Oxidase and Antitumor Properties of Novel 3H-Spiro[Benzo[H] Quinazoline-5,1′-Cyclohexane]-4(6H)-One Derivatives

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

Amides that cyclized into 2-substituted 3H-spiro[benzo(h)quinazoline-5,1′-cyclohexane]-4(6H)-ones were prepared by reaction of 4′-amino-1′H-spiro[cyclohexane-1,2′-naphthalene]-3′-nitrile with carboxylic acid chlorides. Substitution of the benzoquinazolines by alcoholates, secondary amines, and thiolates was investigated. Thus,2-(3-chloropropyl)-3H-spiro[benzo[h]quinazoline-5,1′-cyclohexane]-4(6H)-one underwent intramolecular cyclization to form 10,11-dihydro-5H-spiro[benzo[h]pyrrolo[2,1-b]quinazoline-6,1′-cyclohexane]- 7(9H)-one whereas 2-chloromethyl-3H-spiro[benzo[h]quinazoline-5,1′-cyclohexane]-4(6H)-one formed substitution products. The influence of the synthesized compounds on brain monoamine oxidase activity was studied in vitro. It was found that the majority of the compounds inhibited deamination of 5-HT. The antitumor activity of the compounds was studied using two grafted murine tumor models, i.e., Ehrlich ascites carcinoma and sarcoma 180. Some of the investigated compounds suppressed tumor growth by 50 – 56%.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. A. I. Markosyan, S. V. Dilanyan, R. A. Kuroyan, et al., Khim.-farm. Zh., 29(4), 32 – 34 (1995); Pharm. Chem. J., 29(4), 259 – 269 (1995).

  2. I. Sovadinova, L. Blaha, J. Janosek, K. Hilcherova, et al., Environ. Toxicol. Chem., 25(5), 1291 – 1297 (2008).

    Article  Google Scholar 

  3. B. Van Treist and G. J. Peters, Oncology, 57(3), 179 – 194 (1999).

    Article  Google Scholar 

  4. M. Hanlon and R. Ferone, Cancer Res., 56(14), 3301 – 3306 (1996).

    PubMed  CAS  Google Scholar 

  5. A. I. Markosyan, S. A. Pogosyan, M. S. Safaryan, et al., Khim.-farm. Zh., 41(4), 16 – 18 (2006); Pharm. Chem. J., 41(4), 193 – 196 (2007).

  6. A. I. Markosyan, S. A. Gabrielyan, G. A. Panosyan, et al., Khim.-farm. Zh., 42(2), 6 – 9 (2008).

    Google Scholar 

  7. A. I. Markosyan, M. G. Oganisyan, and R. A. Kuroyan, Khim. Geterotsikl. Soedin., No. 5, 658 – 661 (1992).

  8. R. A. Kuroyan, A. I. Markosyan, A. Sh. Oganisyan, and M. G. Oganisyan, Arm. Khim. Zh., 42(8), 527 (1989).

    CAS  Google Scholar 

  9. G. N. Pershin, Methods of Experimental Chemotherapy [in Russian], Medgiz, Moscow (1971).

    Google Scholar 

  10. Z. P. Sof’ina, A. B. Syrkin, A. Goldin, et al., Experimental Assessment of Antitumor Compounds in the USSR and USA [in Russian], Meditsina, Moscow (1980).

    Google Scholar 

  11. R. R. Safrazbekyan and R. S. Sukasyan, Vopr. Med. Khim., 16, 623 – 628 (1970).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. I. Markosyan.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 48, No. 6, pp. 14 – 18, June, 2014.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Markosyan, A.I., Gabrielyan, S.A., Arsenyan, F.G. et al. Synthesis and Anti-Monoamine Oxidase and Antitumor Properties of Novel 3H-Spiro[Benzo[H] Quinazoline-5,1′-Cyclohexane]-4(6H)-One Derivatives. Pharm Chem J 48, 368–372 (2014). https://doi.org/10.1007/s11094-014-1112-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-014-1112-9

Keywords

Navigation